Nov 18, 2021 07:32PM moth wrote:
just to add to this discussion, the reason they do not recommend the scans is that there is no proof that finding mets earlier is associated with longer survival
& the scans carry their own risk - exposure to radiation or contrast agents etc
So they wait for symptoms of metastatic recurrence & use physical exam & patient reporting. That is why pts should be closely followed by a physician who is aware of their medical history. In a pt who has had cancer before & has a new otherwise unexplained symptom which persist, metastatic disease should be on the differential diagnosis list.
aprilgirl, re recurrence in distant lymph nodes only - I've seen oncologists discuss whether that should be treated as 3C ie. with curative intent. I know someone online with a lymph only met who is NED 5 yrs now.
Initial dx at 50. Seriously?? “Sometimes the future changes quickly and completely and we’re left with only the choice of what to do next." blog: Never Tell Me the OddsDx 12/2017, IDC, Left, 1cm, Stage IA, Grade 3, 0/5 nodes, ER-/PR-, HER2- Surgery 12/12/2017 Lumpectomy; Lumpectomy (Left); Lymph node removal Chemotherapy 2/14/2018 AC + T (Taxol) Radiation Therapy 8/13/2018 Whole breast: Breast Dx 2/2020, IDC, Left, Stage IV, metastasized to liver/lungs, Grade 3, ER-/PR-, HER2- Chemotherapy 3/18/2020 Taxol (paclitaxel) Immunotherapy 3/19/2020 Tecentriq (atezolizumab) Chemotherapy 11/26/2020 Abraxane (albumin-bound or nab-paclitaxel) Radiation Therapy 12/9/2020 External Hormonal Therapy 12/16/2020 Femara (letrozole) Radiation Therapy 3/3/2021 External Local Metastases 3/3/2021 Radiation therapy: Bone Targeted Therapy 1/1/2022 Trodelvy (sacituzumab govitecan-hziy)